MGEL vs TRUALT: Stock Comparison
TRUALT BIOENERGY is the larger company by market capitalisation. MANGALAM GLOBAL ENT shows a higher ROE, a higher dividend yield and faster revenue growth, while TRUALT BIOENERGY shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
MGEL leads 7; TRUALT leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | MGEL | TRUALT |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | MGEL | TRUALT |
|---|---|---|
| Live Price | ₹18.17 | ₹353.25 |
| Day Change | 1.45% | -2.78% |
| Volume | 2.44 L | 1.85 L |
| 52-Week High | ₹19.35 | ₹542 |
| 52-Week Low | ₹9.53 | ₹310.2 |
| Distance from 52W High | -6.1% | -34.82% |
Valuation
| Metric | MGEL | TRUALT |
|---|---|---|
| Market Cap | ₹599 Cr | ₹3,031 Cr |
| P/E Ratio | 14.62x | 13.71x |
| P/B Ratio | 2.11x | 1.87x |
| EPS | ₹0.28 | ₹4.04 |
| Book Value | ₹7.53 | ₹184.06 |
| Dividend Yield | 0.05% | 0% |
Growth
| Metric | MGEL | TRUALT |
|---|---|---|
| Revenue Growth (TTM YoY) | 24.92% | -34.3% |
| EPS Growth (TTM YoY) | -32.83% | -55.8% |
| Qtr Sales Growth | 3.2% | 29.39% |
| Qtr Profit Growth | 9.8% | -40.96% |
Profitability & Leverage
| Metric | MGEL | TRUALT |
|---|---|---|
| ROE | 18.23% | 5.29% |
| ROCE | 15.41% | 6.3% |
| Net Margin | 1.34% | 12.06% |
| Operating Margin | 2.52% | 15.68% |
| Debt to Equity | 0.87x | 1.04x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | MGEL | TRUALT |
|---|---|---|
| Promoter Holding | 68.77%▼ 3.61 pp | 71.38%▲ 0.83 pp |
| FII Holding | 0.16%▲ 0.07 pp | 0.63%▲ 0.05 pp |
| DII Holding | 5.17%▲ 5.17 pp | 9.09%▲ 0.73 pp |
| Public Holding | 25.91%▼ 1.62 pp | 18.91%▼ 1.6 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MANGALAM GLOBAL ENT and TRUALT BIOENERGY.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.